Review
doi: 10.1016/j.crad.2008.05.010.
Epub 2008 Aug 21.
The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma
Affiliations
- PMID: 18996259
- DOI: 10.1016/j.crad.2008.05.010
Item in Clipboard
Review
The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma
Clin Radiol.
2008 Dec.
Abstract
Integrated positron-emission tomography/computed tomography (PET/CT) with 2-[fluorine-18] fluoro-2-deoxy-D-glucose (FDG) is now established in the management of oncology patients. With increasing availability and a constantly advancing body of evidence, the role of FDG PET/CT in oesophageal cancer is set to expand to include initial staging, assessment of disease response, therapy planning, and detection of disease recurrence. This article reviews the utility of FDG PET/CT in the management of oesophageal carcinoma, discussing its role and limitations in the imaging of these patients.
Similar articles
-
Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.Clin Radiol. 2008 Jul;63(7):765-73. doi: 10.1016/j.crad.2008.02.002. Epub 2008 Apr 11. Clin Radiol. 2008. PMID: 18555034
-
PET and PET-CT in esophageal and gastric cancer.Methods Mol Biol. 2011;727:59-76. doi: 10.1007/978-1-61779-062-1_5. Methods Mol Biol. 2011. PMID: 21331929
-
[18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.Postgrad Med J. 2010 Mar;86(1013):174-82. doi: 10.1136/pgmj.2009.079087. Postgrad Med J. 2010. PMID: 20237012 Review.
-
The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.Cancer. 2005 Jan 1;103(1):148-56. doi: 10.1002/cncr.20724. Cancer. 2005. PMID: 15558794 Clinical Trial.
-
PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.Int J Clin Oncol. 2006 Aug;11(4):286-96. doi: 10.1007/s10147-006-0595-0. Int J Clin Oncol. 2006. PMID: 16937302 Review.
Cited by
-
18F-FDG-PET/CT to Detect Pathological Complete Response After Neoadjuvant Treatment in Patients with Cancer of the Esophagus or Gastroesophageal Junction: Accuracy and Long-Term Implications.J Gastrointest Cancer. 2024 Mar;55(1):270-280. doi: 10.1007/s12029-023-00951-2. Epub 2023 Jul 1. J Gastrointest Cancer. 2024. PMID: 37393217 Free PMC article.
-
18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making.PLoS One. 2015 Nov 3;10(11):e0133690. doi: 10.1371/journal.pone.0133690. eCollection 2015. PLoS One. 2015. PMID: 26529313 Free PMC article.
-
Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions.Ann Surg Oncol. 2015 Mar;22(3):1020-5. doi: 10.1245/s10434-014-4079-6. Epub 2014 Sep 19. Ann Surg Oncol. 2015. PMID: 25234017 Free PMC article.
-
Myocardial metastasis from squamous cell carcinoma of the esophagus.Gen Thorac Cardiovasc Surg. 2009 Aug;57(8):440-5. doi: 10.1007/s11748-009-0408-2. Epub 2009 Sep 24. Gen Thorac Cardiovasc Surg. 2009. PMID: 19779796
-
Evaluation of response: is 18F-FDG PET the answer?Eur J Nucl Med Mol Imaging. 2009 May;36(5):733-4. doi: 10.1007/s00259-009-1092-2. Eur J Nucl Med Mol Imaging. 2009. PMID: 19225776 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
